cover
Contact Name
Ahmad Yani
Contact Email
ahmad.yani@poltekkesbanten.ac.id
Phone
+6287812399700
Journal Mail Official
jondpac@poltekkesbanten.ac.id
Editorial Address
Hypertension Prevention and Control Research Center The Polytechnic of Health of Banten Jl. Syekh Nawawi Al Bantani No.12, Banjaragung Cipocok Jaya, Kota Serang, Banten 42121, Indonesia Email: pui-pk@poltekkesbanten.ac.id Ph: 087812399700
Location
Kota serang,
Banten
INDONESIA
Journal of Noncommunicable Diseases Prevention and Control
ISSN : -     EISSN : 29871549     DOI : https://doi.org/10.61843/jondpac
Core Subject : Health, Science,
The Journal of Noncommunicable Diseases Prevention and Control (JONDPAC) is a scientific journal (ISSN 2987-1549) published by the Hypertension Prevention and Control Research Center, the Polytechnic of Health of Banten. This journal publishes regularly, twice a year, in April and October. The journal aims to publish scientific articles related to the efforts of non-communicable diseases prevention and control. Each manuscript submitted to this journal will be double-blind reviewed by experts prior to final acceptance. The articles covered by this journal should be the results of original research, and they could be in the form of clinical or laboratory experimental results or systematic reviews regarding the prevention and control of non-communicable diseases. The specific topics include promotive, preventive, and/or limited curative actions of noncommunicable diseases, risk factor evaluation of noncommunicable diseases, research in biology, molecular biology, or biotechnology related to the prevention and control of noncommunicable diseases, natural product chemistry, drug discovery, or pharmacology in the prevention and control of non-communicable diseases (in vitro, in vivo, or in silico studies), clinical nutrition in relation to the prevention and control of noncommunicable diseases, or other health-related disciplines that cover the prevention and control of non-communicable diseases.
Articles 33 Documents
OVERVIEW OF LACTATE DEHYDROGENASE (LDH) ENZYME ACTIVITY IN HYPERTENSIVE PATIENTS WITH OBESITY AT TANGERANG DISTRICT HOSPITAL Maheswari Syifa Puspamurti; Ramadas A
Journal of Noncommunicable Diseases Prevention and Control Vol. 3 No. 2 (2025): Journal of Noncommunicable Diseases Prevention and Control
Publisher : Hypertension Prevention and Control Research Center, The Polytechnic of Health of Banten

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61843/jondpac.v3i2.998

Abstract

Hypertension is a condition characterized by abnormally high blood pressure. One of the modifiable risk factors for hypertension is obesity. With increased body mass, the heart must pump blood harder, resulting in elevated blood pressure. One type of damage experienced by hypertension sufferers is endothelial dysfunction, which can be a predictor of atherosclerosis. This damage results in the release of the LDH enzyme into the blood. This study aims to determine the overview of LDH enzyme activity in hypertensive patients with obesity at the Tangerang District Hospital. The research design was descriptive and was conducted from March to May 2025. The data collection technique utilized purposive sampling with 26 respondents. The examination method used was the IFCC method. The results showed that LDH enzyme activity in hypertensive patients was high in 8 people (31%). Based on age, high results predominantly occurred in the pre-elderly group (46-60 years) with 5 people (63%). Based on gender, high results were primarily found in women, amounting to 7 people (88%). Based on obesity status, 8 people (100%) with Obesity I had high results. Based on antihypertensive medication consumption, high results were predominantly found in the amlodipine group with 5 people (63%). Future researchers can explore other unexplored factors such as physical activity, dietary patterns, and a history of vitamin C or alcohol consumption.
Relationship Between Blood Pressure Values and High-Density Lipoprotein (HDL) Levels in Hypertensive Patients at Balaraja Hospital Novia Nur Andini; Nining Kurniati; Yuliani, Raden Adjeng Dewi Maria; Nadia Guntari; Priscila Santos
Journal of Noncommunicable Diseases Prevention and Control Vol. 3 No. 1 (2025): Journal of Noncommunicable Diseases Prevention and Control
Publisher : Hypertension Prevention and Control Research Center, The Polytechnic of Health of Banten

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61843/jondpac.v3i1.999

Abstract

Blood pressure and high-density lipoprotein (HDL) levels are two major indicators used in the assessment of cardiovascular health. Both play important roles in the risk of heart disease and stroke. High blood pressure, both systolic and diastolic, is a major risk factor for various cardiovascular diseases. Meanwhile, HDL levels are often considered "good cholesterol" because of their ability to transport cholesterol from the arteries to the liver, where it can be removed from the body. This study aimed to determine the relationship between blood pressure values and high-density lipoprotein levels in hypertensive patients at Balaraja Hospital. This study used a cross-sectional design. The sample consisted of 19 patients who met the inclusion criteria. The examination method used was Cholesterol Oxidase Para Amino Penazon (CHOD-PAP). The normality test results showed a p-value of p = 0.101 for HDL levels, p = 0.006 for systolic blood pressure, and p = 0.018 for diastolic blood pressure, indicating that HDL levels could be considered normally distributed, whereas blood pressure was not normally distributed. Therefore, further analysis used a correlation test. The results of Spearman rank correlation showed a significance value of p = 0.062 for systolic blood pressure and p = 0.190 for diastolic blood pressure, indicating that there was no significant relationship between HDL levels and blood pressure, with a very weak correlation for systolic blood pressure (r = 0.010) and diastolic blood pressure (r = 0.190). The conclusion of this study was that there was no significant relationship between blood pressure and HDL levels in hypertensive patients at Balaraja Hospital.
Overview of Total Cholesterol Levels in Prolanis Hypertensive Patients at the Kelapa Dua Community Health Center Endah Cahya Nisa Anastasya; Syarah Anliza; Adipura atmadja Egok; Citra Trisna; Basil Okeahiam
Journal of Noncommunicable Diseases Prevention and Control Vol. 3 No. 2 (2025): Journal of Noncommunicable Diseases Prevention and Control
Publisher : Hypertension Prevention and Control Research Center, The Polytechnic of Health of Banten

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61843/jondpac.v3i2.1000

Abstract

Hypertension is one of the non-communicable diseases whose prevalence continues to increase each year and contributes substantially to the risk of cardiovascular disease, especially when accompanied by high total cholesterol levels. This study aimed to describe total cholesterol levels among hypertensive patients participating in the Chronic Disease Management Program (Prolanis) at the Kelapa Dua Community Health Center, Tangerang Regency. This study used a descriptive design with a cross-sectional approach, and the sample consisted of 25 hypertensive Prolanis patients at the Kelapa Dua Community Health Center. Total cholesterol was examined using the CHOD-PAP method. The results showed that borderline-high total cholesterol levels by age were most common in the middle-aged group (45-59 years), with 7 respondents (64%), while 4 respondents (80%) had high cholesterol levels. Based on sex, high total cholesterol levels were found in 10 female respondents (91%) and 1 male respondent (9%). Based on the classification of total cholesterol levels by hypertension category, high total cholesterol was most frequently found in grade 1 hypertension, with 5 respondents (63%), while borderline-high cholesterol was found in 3 respondents (33%).

Page 4 of 4 | Total Record : 33